MTOR and liver dysplastic nodule: However, it is not known whether pathogenic factors of DN in turn affect mTOR/TFEB-mediated lysosomal biogenesis and clearance, resulting in the impairment of lysosomal homeostasis in TECs and, if so, whether TFEB activation could maintain lysosomal homeostasis and thus alleviate TECs injuries under diabetic conditions.